Biotech

All Articles

BioAge eyes $180M coming from IPO, exclusive placement for obesity trials

.BioAge Labs is actually looking at about $180 thousand in initial earnings coming from an IPO and a...

Merck's LAG-3 combination neglects colon cancer cells phase 3 research

.A try through Merck &amp Co. to open the microsatellite steady (MSS) metastatic colon cancer cells ...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand euros ($ 200 million), loan th...

BioAge introduces $198M coming from IPO as obesity biotech signs up with Nasdaq

.BioAge Labs is generating almost $200 thousand using its Nasdaq IPO today, with the profits allocat...

Acadia takes BMS vet on board as CEO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Cassava spends $40M over supposedly misleading Alzheimer's upgrade

.Cassava Sciences has consented to spend $40 thousand to settle an investigation in to cases it made...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has picked up choices on 2 Evaxion Biotech vaccination applicants, paying $3.2 thous...

Enanta's RSV antiviral crushes viral lots in obstacle research study

.Enanta Pharmaceuticals has linked its respiratory system syncytial virus (RSV) antiviral to signifi...

Biogen cans SAGE-324 partnership after important agitation neglect

.Biogen has carried out the last ceremonies to its partnership with Sage Therapeutics on SAGE-324, b...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's ailment drugs are being actually questioned, AbbVie has ...